Literature DB >> 21254906

Prognostic significance of serum cholesterol, lathosterol, and sitosterol in old age; a 17-year population study.

Reijo S Tilvis1, Jaakko N Valvanne, Timo E Strandberg, Tatu A Miettinen.   

Abstract

BACKGROUND. Low serum total cholesterol is frequently associated with worse survival in older people, but mechanisms of this association are poorly understood. AIMS. Characteristics of cholesterol metabolism were related to survival in a random 75 + population sample. METHODS. Serum cholesterol and lathosterol, and sitosterol were measured in random persons (n = 623) of birth cohorts (1904, 1909, and 1914) in 1990, and all persons were followed for 17 years. RESULTS. Total cholesterol declined in old age, and low cholesterol was associated with poor health and multi-morbidity. Cholesterol below 5.0 mmol/L was associated with accelerated all-cause mortality (age- and gender-adjusted hazard ratio (HR) 1.54; 95% CI 1.21-1.97; P < 0.001) and vascular mortality (HR 2.13 (1.42-3.07); P < 0.001). Lathosterol (indicating cholesterol synthesis) and sitosterol (indicating cholesterol absorption) also decreased with deteriorating health. Low lathosterol, sitosterol, and cholesterol predicted mortality additively and independently of each other. When all three sterols were high (> median) or low, the age- and gender-adjusted survival was 9.9 and 5.6 years (P < 0.001). CONCLUSION. Lower synthesis and absorption of cholesterol, and low serum cholesterol level are associated with deteriorating health and indicate impaired survival in old age.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254906     DOI: 10.3109/07853890.2010.546363

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  14 in total

1.  The U-shaped Relationship of Traditional Cardiovascular Risk Factors and Adverse Outcomes in Later Life.

Authors:  Ahmed H Abdelhafiz; Boon Eng Loo; Nicola Hensey; Claire Bailey; Alan Sinclair
Journal:  Aging Dis       Date:  2012-10-17       Impact factor: 6.745

2.  Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.

Authors:  Marco Bertolotti; Carlotta Franchi; Marco B L Rocchi; Andrea Miceli; M Vittoria Libbra; Alessandro Nobili; Giulia Lancellotti; Lucia Carulli; Chiara Mussi
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

3.  Prognostic factors of long-term survival in geriatric inpatients. Should we change the recommendations for the oldest people?

Authors:  B Bień; K Bień-Barkowska; A Wojskowicz; A Kasiukiewicz; Z B Wojszel
Journal:  J Nutr Health Aging       Date:  2015-04       Impact factor: 4.075

4.  Statin treatment, phenotypic frailty and mortality among community-dwelling octogenarian men: the HBS cohort.

Authors:  Kari Luotola; Satu Jyväkorpi; Annele Urtamo; Kaisu H Pitkälä; Mika Kivimäki; Timo E Strandberg
Journal:  Age Ageing       Date:  2020-02-27       Impact factor: 10.668

5.  Longitudinal trajectories of cholesterol from midlife through late life according to apolipoprotein E allele status.

Authors:  Brian Downer; Steven Estus; Yuriko Katsumata; David W Fardo
Journal:  Int J Environ Res Public Health       Date:  2014-10-16       Impact factor: 4.614

6.  Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome.

Authors:  Zhi Liu; Hengjian Hao; Chunlin Yin; Yanyan Chu; Jing Li; Dong Xu
Journal:  Oncotarget       Date:  2017-06-20

7.  Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in Framingham Offspring Study participants.

Authors:  Nirupa R Matthan; Lei Zhu; Michael Pencina; Ralph B D'Agostino; Ernst J Schaefer; Alice H Lichtenstein
Journal:  J Am Heart Assoc       Date:  2013-02-19       Impact factor: 5.501

8.  A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19.

Authors:  Sin Man Lam; Chao Zhang; Zehua Wang; Zhen Ni; Shaohua Zhang; Siyuan Yang; Xiahe Huang; Lesong Mo; Jie Li; Bernett Lee; Mei Mei; Lei Huang; Ming Shi; Zhe Xu; Fan-Ping Meng; Wen-Jing Cao; Ming-Ju Zhou; Lei Shi; Gek Huey Chua; Bowen Li; Jiabao Cao; Jun Wang; Shilai Bao; Yingchun Wang; Jin-Wen Song; Fujie Zhang; Fu-Sheng Wang; Guanghou Shui
Journal:  Nat Metab       Date:  2021-06-22

Review 9.  Statins for primary cardiovascular prevention in the elderly.

Authors:  Juan Pedro-Botet; Elisenda Climent; Juan J Chillarón; Rocio Toro; David Benaiges; Juana A Flores-Le Roux
Journal:  J Geriatr Cardiol       Date:  2015-07       Impact factor: 3.327

10.  Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population.

Authors:  Marco Bertolotti; Chiara Mussi; Elisa Pellegrini; Alessandro Magni; Marina Del Puppo; Silvia Ognibene; Lucia Carulli; Claudia Anzivino; Enrica Baldelli; Paola Loria; Nicola Carulli
Journal:  Clin Interv Aging       Date:  2014-03-17       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.